CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 103 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q2 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $99,000 | +106.2% | 50,289 | +30.9% | 0.00% | – |
Q4 2020 | $48,000 | -11.1% | 38,411 | +28.3% | 0.00% | – |
Q3 2020 | $54,000 | -82.4% | 29,947 | -22.9% | 0.00% | – |
Q2 2020 | $307,000 | +45.5% | 38,860 | -3.5% | 0.00% | – |
Q1 2020 | $211,000 | +8.2% | 40,288 | +12.8% | 0.00% | – |
Q4 2019 | $195,000 | +4.3% | 35,728 | -4.4% | 0.00% | – |
Q3 2019 | $187,000 | -27.8% | 37,389 | 0.0% | 0.00% | – |
Q2 2019 | $259,000 | +4.4% | 37,389 | +4.8% | 0.00% | – |
Q1 2019 | $248,000 | +29.2% | 35,681 | +8.2% | 0.00% | – |
Q4 2018 | $192,000 | -26.7% | 32,964 | -5.2% | 0.00% | – |
Q3 2018 | $262,000 | +24.8% | 34,762 | -16.3% | 0.00% | – |
Q2 2018 | $210,000 | -12.1% | 41,537 | +6.4% | 0.00% | – |
Q1 2018 | $239,000 | -11.5% | 39,053 | +2.5% | 0.00% | – |
Q4 2017 | $270,000 | +7.6% | 38,103 | +8.6% | 0.00% | – |
Q3 2017 | $251,000 | +10.1% | 35,086 | -3.0% | 0.00% | – |
Q2 2017 | $228,000 | +1241.2% | 36,181 | +1347.2% | 0.00% | – |
Q3 2016 | $17,000 | – | 2,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 5,045,870 | $27,550,000 | 20.34% |
AdvisorShares Investments LLC | 380,750 | $2,079,000 | 1.29% |
ETF MANAGERS GROUP, LLC | 5,779,642 | $31,557,000 | 1.10% |
DAFNA Capital Management LLC | 297,300 | $1,623,000 | 0.56% |
GENERAL AMERICAN INVESTORS CO INC | 632,400 | $3,453,000 | 0.32% |
Aries Wealth Management | 27,900 | $160,000 | 0.10% |
Virtus ETF Advisers LLC | 81,751 | $446,000 | 0.07% |
Omnia Family Wealth, LLC | 21,726 | $119,000 | 0.06% |
HighVista Strategies LLC | 12,200 | $67,000 | 0.05% |
WOODSTOCK CORP | 57,213 | $312,000 | 0.05% |